Paula Munderi

UVRI P.O.Box 49, Plot 51-59 Nakiwogo Road
Entebbe, C, Uganda

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

The impact of viraemia on inflammatory biomarkers and CD4+ cell subpopulations in HIV-infected children in sub-Saharan Africa.

The impact of viraemia on inflammatory biomarkers and CD4+ cell subpopulations in HIV-infected children in sub-Saharan Africa.

Journal: AIDS (London, England)

Published: July 16, 2021

Phylogenetic analysis of HIV-1 shows frequent cross-country transmission and local population expansions.

Phylogenetic analysis of HIV-1 shows frequent cross-country transmission and local population expansions.

Journal: Virus evolution

Published: August 10, 2020

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30-49 vs ≥50 mL/min.

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30-49 vs ≥50 mL/min.

Journal: PloS one

Published: July 30, 2019

Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural Uganda.

Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural Uganda.

Journal: HIV medicine

Published: July 04, 2019

Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus-Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy.

Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus-Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy.

Journal: The Journal of infectious diseases

Published: May 14, 2019

Dyslipidemias and cardiovascular risk scores in urban and rural populations in north-western Tanzania and southern Uganda.

Dyslipidemias and cardiovascular risk scores in urban and rural populations in north-western Tanzania and southern Uganda.

Journal: PloS one

Published: March 14, 2019

Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV.

Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV.

Journal: Southern African journal of HIV medicine

Published: January 24, 2019

Prevalence of high blood pressure and associated factors among adolescents and young people in Tanzania and Uganda.

Prevalence of high blood pressure and associated factors among adolescents and young people in Tanzania and Uganda.

Journal: Journal of clinical hypertension (Greenwich, Conn.)

Published: August 23, 2018

Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial.

Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial.

Journal: PloS one

Published: July 04, 2018

Expert consensus statement on the science of HIV in the context of criminal law.

Expert consensus statement on the science of HIV in the context of criminal law.

Journal: Journal of the International AIDS Society

Published: October 09, 2017

Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial.

Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial.

Journal: Open forum infectious diseases

Published: August 18, 2017

Viable dual therapy second-line antiretroviral regimen for Africa?

Viable dual therapy second-line antiretroviral regimen for Africa?

Journal: The lancet. HIV

Published: April 12, 2017

Showing 1-12 of 52

Last Updated: 09/26/2026